EFG
ELDN icon

Everhart Financial Group’s Eledon Pharmaceuticals ELDN Stock Holding History

Everhart Financial Group’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Hold
10,000
– – ﹤0.01% 479
2026
Q1 		$30.8K Buy
+10,000
New +$23.6K ﹤0.01% 459

Other funds holding ELDN

PAM
Prodigy Asset Management Omaha, Nebraska $332M AUM 10.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HFS
Howard Financial Services Dallas, Texas $1B AUM 20.02% 1-Year Est. Return
RZH
Relyea Zuckerberg Hanson Stamford, Connecticut $1.2B AUM 28.45% 1-Year Est. Return
RWP
Revolve Wealth Partners Hackensack, New Jersey $965M AUM 22.88% 1-Year Est. Return
GWM
GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
FMII
Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Everhart Financial Group's ELDN Position: Q2 2026 in Review

Everhart Financial Group held its Eledon Pharmaceuticals (ELDN) position steady in Q2 2026 at 10,000 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Everhart Financial Group first reported a position in ELDN in Q1 2026 and has held it in 2 quarters since. 16 funds tracked by Wall St. Rank hold ELDN as of Q2 2026.

  • Everhart Financial Group held 10,000 shares of Eledon Pharmaceuticals worth $39.4K as of Q2 2026.
  • Everhart Financial Group left its Eledon Pharmaceuticals share count unchanged in Q2 2026.
  • Eledon Pharmaceuticals made up ﹤0.01% of Everhart Financial Group's portfolio in Q2 2026, its #479 holding.
  • Everhart Financial Group first reported a position in Eledon Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 16 funds tracked by Wall St. Rank held Eledon Pharmaceuticals as of Q2 2026.

Based on Everhart Financial Group's 13F filing for Q2 2026, filed 9 Jul 2026.